CHINA PHARMA HOLDINGS, INC. Operating Lease Right-of-Use Assets
CHINA PHARMA HOLDINGS, INC. (CPHI) had Operating Lease Right-of-Use Assets of $146.18 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $146.18K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $161.88K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $181.83K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $197.85K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $146.18K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $161.88K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $181.83K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $197.85K 10-Q · filed 2025-11-12 |
| 2025-03-31 | $19.18K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $38.30K 10-K · filed 2026-04-01 |
| 2024-09-30 | $58.93K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $77.26K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $116.61K 10-K · filed 2025-03-31 |
| 2023-09-30 | $134.21K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $152.40K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $19.79K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $39.05K 10-K · filed 2024-04-01 |
| 2022-09-30 | $57.45K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $81.04K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $107.09K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $127.96K 10-K · filed 2023-03-30 |
| 2021-09-30 | $146.76K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $169.81K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $25.37K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $49.69K 10-K · filed 2022-03-30 |
| 2020-09-30 | $70.73K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $90.29K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $112.45K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $136.78K 10-K · filed 2021-03-26 |
| 2019-09-30 | $157.18K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $184.62K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $212.59K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |